Home » Topics » Medical technology

Medical technology
RSS

Money Raised Year To Date

Dec. 6, 2004

Still Fighting, Genta Acquires Phase I Antisense Drug Rights

Dec. 6, 2004

Appointments And Advancements

Dec. 6, 2004

BioWorld Stock Report For Public Biotechnology Companies

Dec. 6, 2004

Venture Capital And Corporate Investments In Biotechnology Companies: November 2004

Dec. 6, 2004

Genta's Antisense Bid Flops But Others Won't Give Up

Dec. 6, 2004

BioSante Affected By FDA Panel Vote On P&G Product

Dec. 6, 2004

By Aaron Lorenzo

Other News To Note

Dec. 6, 2004

Stock Indexes

Dec. 6, 2004

Stock Winners and Losers For The Week

Dec. 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...